European indapamide market is estimated to grow significantly at a CAGR of around 3.2% during the forecast period. Europe has a huge economic burden of heart-related diseases such as CVD, CHD, stroke, and other heart diseases. Europe region including UK, Spain, Germany, France, Italy, Sweden, and other EU countries have a huge pool of CVD patients that creates scope for the growth of the indapamide market. The European Stroke Organization (ESO) and Stroke Alliance for Europe (SAFE) published European Stroke Action Plan (ESAP) in May 2018. The aim of the plan is to set a roadmap and goals for the treatment of stroke in Europe by 2030.Indapamide is used as a preventive treatment of stroke in combination with perindopril, therefore, the growing stroke cases in the region further contribute to the growth of the market during the forecast period.

Request a Free Sample of our European Indapamide Market: https://www.omrglobal.com/request-sample/european-indapamide-market

The European indapamide market is segmented on the basis of product and application. Based on product, the market is bifurcated into 1.25 mg and 2.5 mg. Among these, the market for 1.25 mg medicine held the significant market share owing to the extensive application of the drug in treating high blood pressure or hypertension. Based on the application, the market is segmented into high blood pressure, heart failure, and others. The high blood pressure segment is projected to have significant share in the market. Growing incidence of hypertension is contributing to market growth as indapamide drugs are significantly used to treat hypertension while reducing the risk of developing serious heart conditions.

A full Report of European Indapamide Market is Available at: https://www.omrglobal.com/industry-reports/european-indapamide-market

European Indapamide Market Segmentation

By Product

• 1.25 MG
• 2.5 MG

By Application

• High Blood Pressure
• Heart Failure
• Others

Regional Analysis

• UK
• Germany
• France
• Italy
• Spain
• Rest of Europe

Company Profiles

• Bioindustria L.I.M. S.p.A.
• Grupo Azevedos
• Krka Group
• Laboratori Baldacci S.p.A.
• Merck KGaA
• Mylan N.V.
• Sandoz International GmbH
• Sanofi S.A.
• Servier Group
• Teva Pharmaceuticals Industries Ltd.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/european-indapamide-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit Orion Market Research

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 7803040404